Mod­er­na so­lid­i­fies deal with Kenya to build mR­NA man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Deals
Pharma

Ther­mo Fish­er moves on cam­pus with new cell man­u­fac­tur­ing site in San Fran­cis­co

3 years ago
Pharma
Manufacturing

Nanoscope’s eye dis­ease gene ther­a­py shows mixed re­sults in PhII

3 years ago
R&D
Cell/Gene Tx

FDA grants full ap­proval to Keytru­da in tu­mor-ag­nos­tic set­ting; Can­del paus­es tri­al en­roll­ment

3 years ago
News Briefing

FDA lifts par­tial clin­i­cal hold on Vig­il Neu­ro­science's TREM2 an­ti­body, re­mov­ing dos­ing cap

3 years ago
FDA+

Dai­ichi Sankyo inks $183M dis­cov­ery deal with GPCR biotech for CNS tar­get

3 years ago
Deals
R&D

Dif­fu­sion to hand Nas­daq spot to EIP Phar­ma for PhI­Ib de­men­tia study of ex-Ver­tex drug

3 years ago
Deals
R&D

GSK picks up Scynex­is' FDA-ap­proved an­ti­fun­gal drug for $90M up­front

3 years ago
Deals
Pharma

See­los Ther­a­peu­tics 'tem­porar­i­ly' stops study in rare neu­ro dis­or­der for busi­ness rea­sons

3 years ago
R&D

Alec­tor cuts 11% of work­force as it dou­bles down on late-stage neu­ro pro­grams part­nered with GSK, Ab­b­Vie

3 years ago
People
R&D

Hear­ing-fo­cused biotech grabs trio of pro­grams from Oton­o­my's fire sale

3 years ago
Deals

Math­ai Mam­men hands in J&J's R&D keys to lead Greg Ver­dine’s Fog­Phar­ma 

3 years ago
People
Startups

Q&A: New­ly-mint­ed CSL chief ex­ec­u­tive Paul McKen­zie and chief med­ical of­fi­cer Bill Mez­zan­otte

3 years ago
People
Pharma

UK gov­ern­ment, pri­vate in­vestors dole out $340M+ to drug, di­ag­nos­tic man­u­fac­tur­ers

3 years ago
Financing
Manufacturing

Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

3 years ago
Financing
Pharma

Ot­su­ka, Lund­beck eye Alzheimer's in­di­ca­tion in FDA ad­comm for Rex­ul­ti la­bel ex­pan­sion

3 years ago
Pharma
FDA+

Phar­maron ex­pand­ing Liv­er­pool man­u­fac­tur­ing fa­cil­i­ty with a $186M+ price tag

3 years ago
China
Manufacturing

Boehringer re­ports ro­bust sales led by type 2 di­a­betes and pul­monary drugs, promis­es more to come high­light­ing ...

3 years ago
Pharma
Marketing

In search of new way to de­liv­er gene ed­i­tors, CRISPR pi­o­neer turns to mol­e­c­u­lar sy­ringes

3 years ago
R&D
Discovery

Monopar puts a stop to its chemo com­pli­ca­tion drug; Ex­i­cure ex­plores fu­ture trans­ac­tions

3 years ago
News Briefing

Blue­bird to miss Q1 dead­line for lo­vo-cel fil­ing, shares sliced

3 years ago
FDA+

Lay­offs hit pri­vate gene ther­a­py star­tups, mi­graine biotech Sat­suma as in­dus­try squeeze doesn’t let up

3 years ago
People

Por­tal In­no­va­tions takes its Chica­go biotech in­vest­ing, lab space mod­el to Boston with Bob Langer start­up in tow

3 years ago
Financing
Startups

FDA ap­proves Nar­can opi­oid over­dose re­ver­sal spray for over-the-counter sale

3 years ago
Pharma
FDA+
First page Previous page 353354355356357358359 Next page Last page
A service from the Financial Times